Pharmaceuticals
Bayer explores potential bid for Monsanto Co
13 May 2016
Gilead gets Indian patent for hepatitis drug Sofosbuvir
10 May 2016
Non-profits like MSF and other consumer bodies say Indian authorities have bowed to US pressure in granting a patent to the hepatitis-C drug, which costs $1,000 per pill in the US
Ranbaxy ex-bosses to challenge Rs2,562-cr fine for hiding info from Daiichi
06 May 2016
In a majority ruling this week, a three-member arbitration panel in Singapore imposed a fine on the billionaire brothers earlier this week in a case filed by Daiichi Sankyo in 2013
.webp)
